The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 1 March 2005, www.theannals.com, DOI 10.1345/aph.1E139.
The Annals of Pharmacotherapy: Vol. 39, No. 4, pp. 691-698. DOI 10.1345/aph.1E139
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kozyra, E. F
Right arrow Articles by Burry, L. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kozyra, E. F
Right arrow Articles by Burry, L. D

CRITICAL CARE

Can 1 µg of Cosyntropin Be Used to Evaluate Adrenal Insufficiency in Critically Ill Patients?

Elizabeth F Kozyra, BSc(Phm) PharmD

at time of writing, on clinical placement in the Medical-Surgical ICU, Mount Sinai Hospital, Toronto, Ontario, Canada; now, Clinical Pharmacy Specialist–Nephrology, Health Care Corporation of St. John's; Assistant Professor, School of Pharmacy, Memorial University of Newfoundland, St. John's, Newfoundland, Canada

Randy S Wax, MD FRCPC

Critical Care Physician, Department of Medicine, Mount Sinai Hospital; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Lisa D Burry, BScPharm PharmD FCCP

Critical Care Specialist, Surgical Team Leader, Education Coordinator, Department of Pharmacy, Mount Sinai Hospital

Reprints: Dr. Burry, Department of Pharmacy, Rm. 1506, Mount Sinai Hospital, 600 University Ave., Toronto, Ontario M5G 1X5, Canada, fax 416/586-8353, lburry{at}mtsinai.on.ca

OBJECTIVE: To evaluate the utility of cosyntropin 1 µg in assessing adrenal function in critically ill patients.

DATA SOURCES: A computerized literature search using MEDLINE, EMBASE, International Pharmaceutical Abstracts, and the Cochrane Database (1966–August 2004) was undertaken for trials evaluating cosyntropin 1 µg using the following search terms: adrenocorticotropin-releasing hormone (ACTH), cosyntropin, adrenal insufficiency, cortisol, corticosteroids, glucocorticoids, sepsis, septic shock, diagnosis, critically ill, intensive care, and critical care.

STUDY SELECTION AND DATA SYNTHESIS: Identifying patients with sepsis with relative adrenal insufficiency (AI) using cosyntropin testing may identify those likely to benefit from corticosteroids. The results of 5 heterogeneous studies in non–intensive care unit (ICU) patients suggest that both 1 µg and 250 µg of cosyntropin stimulate similar cortisol responses and that testing using both doses correlates well with results from insulin tolerance testing. Some data from non-ICU patients suggest that the 1-µg test may be more sensitive to detect AI; 3 heterogeneous studies in ICU patients confirmed the improved sensitivity of the 1-µg test.

CONCLUSIONS: Use of cosyntropin 1 µg should detect AI in all patients who would have been diagnosed using 250 µg. Unfortunately, all of the clinical trials evaluating the role of corticosteroids in septic shock that used the cosyntropin stimulation test administered 250 µg. Extrapolation of the existing guidelines to treat patients with septic shock testing positive for relative AI using the 1-µg test may provide effective therapy to appropriate patients not diagnosed by the 250-µg testing or may introduce additional adverse effects in patients who should not receive corticosteroids. Large-scale, head-to-head comparison data of steroid effectiveness after 1- and 250-µg ACTH stimulation tests are needed to expand upon these promising results.

Key Words: adrenal insufficiency, corticosteroids, cortisol, cosyntropin

Published Online, March 1, 2005. www.theannals.com, DOI 10.1345/aph.1E139


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
Z. Thomas and G. L Fraser
An Update on the Diagnosis of Adrenal Insufficiency and the Use of Corticotherapy in Critical Illness
Ann. Pharmacother., September 1, 2007; 41(9): 1456 - 1465.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. Arafah
Hypothalamic Pituitary Adrenal Function during Critical Illness: Limitations of Current Assessment Methods
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3725 - 3745.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
P. M. Szumita, B. C. Greenwood, C. M. Lowry, and M. E. Wechsler
Using the high-dose corticotropin test to diagnose relative adrenal insufficiency in vasopressor-dependent septic shock
Am. J. Health Syst. Pharm., March 1, 2006; 63(5): 466 - 471.
[Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.